Skip to main content
Figure 3 | Malaria Journal

Figure 3

From: Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya

Figure 3

Prevalence of dhfr triple mutant, dhps double mutant and the combined dhfr / dhps quintuple genotype before and after IPTp policy adoption. Years with fewer than 25 samples were merged with either the previous year or after, depending on the number of samples in that particular year. The bars represent 95 % CI. No samples were collected in 2001 and therefore data for this year was not presented. For 1996–2000 and 2002–2008 periods, only history of SP use (case management or any dose of IPTp-SP) in pregnancy was documented while IPTp use was recorded for 2008–2009.

Back to article page